Risk of myocardial infarction related to factor V Leiden mutation: a meta-analysis

Moataz Dowaidar1, Ahmad Settin

  • 1Genetics Unit, Egypt and Research Center, College of Medicine, Qassim University, Mansoura University Children Hospital, Buraydah, Saudi Arabia.

Abstract

Insights

The factor V Leiden (FVL) mutation increases the risk of myocardial infarction (MI). This genetic factor is more frequent in MI patients than in healthy individuals, highlighting its clinical significance.

Area of Science:

  • Cardiovascular Genetics
  • Thrombophilia Research
  • Molecular Epidemiology

Background:

  • Myocardial infarction (MI) is linked to inherited thrombophilia, specifically resistance to activated protein C due to the factor V Leiden (FVL) mutation.
  • Understanding the prevalence and risk associated with FVL mutation in MI is crucial for cardiovascular disease research.

Purpose of the Study:

  • To determine the frequency of the FVL mutation in myocardial infarction (MI) cases across diverse populations.
  • To quantify the overall risk of MI associated with carrying the FVL mutation.

Main Methods:

  • A meta-analysis was conducted on data from 41 studies.
  • Included were 7,790 MI cases and 19,276 healthy controls.
  • Frequencies and odds ratios for FVL mutation were compared between groups.

Main Results:

  • The FVL mutation was found in 6.791% of MI cases versus 1.304% of controls.
  • An overall odds ratio of 1.608 (95% CI: 1.98-4.44) indicated a significantly increased risk of MI associated with FVL mutation.
  • Significant variations in FVL mutation frequency were observed among different populations.

Conclusions:

  • Carriage of the factor V Leiden mutation presents a definitive risk for myocardial infarction.
  • Findings have implications for genetic counseling and prophylactic strategies for families of MI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...